Home › Companies › TRANSMEDICS GROUP INC. › 2024-2025

TRANSMEDICS GROUP INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and TRANSMEDICS GROUP INC.’s Form 8-K, filed 2025-05-23 (Item 5.07 on EDGAR). Page generated 04 October 2026.

  • 12Reported items
  • 347Asset managers
  • 3,318Fund votes
  • 2025-05-22Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore TRANSMEDICS GROUP INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by TRANSMEDICS GROUP INC.

These tallies are TRANSMEDICS GROUP INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-05-23 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

TRANSMEDICS GROUP INC. — official shareholder meeting results, meeting held 2025-05-22
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Waleed Hassanein, M.D 21,530,830124,81638,595 --4,939,164 Majority: yes
Elect Director: James R. Tobin 21,154,414491,44148,386 --4,939,164 Majority: yes
Elect Director: Edward M. Basile 19,518,0212,128,24747,973 --4,939,164 Majority: yes
Elect Director: Thomas J. Gunderson 21,367,800277,96248,479 --4,939,164 Majority: yes
Elect Director: Edwin M. Kania, Jr. 19,583,1042,062,27848,859 --4,939,164 Majority: yes
Elect Director: Stephanie Lovell 21,338,519305,59750,125 --4,939,164 Majority: yes
Elect Director: Merilee Raines 21,421,630224,81547,796 --4,939,164 Majority: yes
Elect Director: David Weill, M.D. 21,250,720395,20748,314 --4,939,164 Majority: yes
Proposal Two : The shareholders approved, on a non-binding advisory basis, the compensation paid to the Company's named executive officers, based on the following votes: 20,883,760755,96254,519 --4,939,164 Majority: yes

Source: TRANSMEDICS GROUP INC., Form 8-K, filed with the SEC on 2025-05-23 — read the filing on EDGAR.

How asset managers voted at the TRANSMEDICS GROUP INC. 2024-2025 meeting

Each item below shows how the 347 asset managers that disclosed a TRANSMEDICS GROUP INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of TRANSMEDICS GROUP INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2025-05-22.

Combines 10 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 20,883,760AGAINST: 755,962

TRANSMEDICS GROUP INC.’s own tally for this item (“Proposal Two : The shareholders approved, on a non-binding advisory basis, the compensation paid to the Company's named executive officers, based on the following votes:”): 20,883,760 for, 755,962 against, per its Form 8-K filed 2025-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 33,827,880 outstanding shares: 62% for, 2% against (64% of the company cast a for/against vote).

The 341 asset managers below cast 98% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 97%
FOR: 97.5%AGAINST: 2.5%ABSTAIN: 0.0%NOT VOTED: 0.0%
Largest asset managers voting on “To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named executive officers.” at TRANSMEDICS GROUP INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity7,252,5370 00For
Vanguard3,552,9841,371 00For
BlackRock2,303,608546 00For
MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST1,007,6650 00For
Delaware/Macquarie768,4880 00For
MUTUAL FUND SERIES TRUST674,7160 00For
Charles Schwab573,9800 00For
JPMorgan522,8670 00For
Liontrust Investment Partners LLP522,3620 00For
DRIEHAUS CAPITAL MANAGEMENT LLC500,5400 00For
State Street397,5520 00For
WASATCH ADVISORS LP372,9590 00For
WASATCH FUNDS TRUST333,2150 00For
Invesco0328,407 00Against
BRAIDWELL LP312,9470 00For
Royce295,4600 00For
Hood River Capital Management LLC290,2220 00For
Northern Trust274,0430 00For
EMERALD MUTUAL FUND ADVISERS TRUST262,3450 00For
BROWN CAPITAL MANAGEMENT LLC219,1920 00For
PRINCIPAL GLOBAL INVESTORS198,5530 00For
BAILLIE GIFFORD & CO LTD185,6570 00For
Wellington175,8000 00For
EMERALD ADVISERS, LLC167,6830 00For
Bridge Builder Trust149,4790 00For

Showing the 25 largest of 341 asset managers. See all 341 in the interactive database.

2. Election of Directors: Waleed H. Hassanein, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-22.

Combines 3 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%
FOR: 21,530,830AGAINST: 124,816

TRANSMEDICS GROUP INC.’s own tally for this item (“Elect Director: Waleed Hassanein, M.D”): 21,530,830 for, 124,816 against, per its Form 8-K filed 2025-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 33,827,880 outstanding shares: 64% for, 0.4% against (64% of the company cast a for/against vote).

The 92 asset managers below cast 99.9% of the shares they voted on this item FOR (12,646,757 for, 2 against).

FOR 99.9%
FOR: 12,646,757 (100.0%)AGAINST: 2 (0.0%)ABSTAIN: 4,796 (0.0%)
Largest asset managers voting on “Election of Directors: Waleed H. Hassanein, M.D.” at TRANSMEDICS GROUP INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,478,0960 00For
Fidelity2,943,9490 00For
BlackRock1,642,2360 00For
Delaware/Macquarie768,4880 00For
MUTUAL FUND SERIES TRUST674,7160 00For
WASATCH FUNDS TRUST333,2150 00For
Royce295,4600 00For
Charles Schwab270,5830 00For
JPMorgan184,1470 00For
Bridge Builder Trust149,4790 00For
Invesco148,0790 00For
Brown Capital Management Mutual Funds145,2870 00For
Principal137,7520 00For
FINANCIAL INVESTORS TRUST132,7200 00For
Hartford110,5890 00For
DRIEHAUS MUTUAL FUNDS104,9540 00For
Columbia Threadneedle90,9340 00For
Waddell & Reed83,2430 00For
Lincoln Financial81,9220 00For
Equitable72,8950 00For
QUANTITATIVE MASTER SERIES LLC55,3970 00For
Jackson National41,6900 00For
Janus Detroit Street Trust37,6880 00For
RBB FUND, INC.36,7900 00For
Empower31,8070 00For

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

3. Election of Directors: James R. Tobin

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-22.

Combines 2 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 21,154,414AGAINST: 491,441

TRANSMEDICS GROUP INC.’s own tally for this item (“Elect Director: James R. Tobin”): 21,154,414 for, 491,441 against, per its Form 8-K filed 2025-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 33,827,880 outstanding shares: 63% for, 1% against (64% of the company cast a for/against vote).

The 92 asset managers below cast 99.8% of the shares they voted on this item FOR (12,628,932 for, 17,827 against).

FOR 99.8%
FOR: 12,628,932 (99.8%)AGAINST: 17,827 (0.1%)ABSTAIN: 4,796 (0.0%)
Largest asset managers voting on “Election of Directors: James R. Tobin” at TRANSMEDICS GROUP INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,476,7251,371 00For
Fidelity2,943,9490 00For
BlackRock1,642,2360 00For
Delaware/Macquarie768,4880 00For
MUTUAL FUND SERIES TRUST674,7160 00For
WASATCH FUNDS TRUST333,2150 00For
Royce295,4600 00For
Charles Schwab270,5830 00For
JPMorgan184,1470 00For
Bridge Builder Trust143,4346,045 00For
Invesco148,0790 00For
Brown Capital Management Mutual Funds145,2870 00For
Principal137,7520 00For
FINANCIAL INVESTORS TRUST132,7200 00For
Hartford110,5890 00For
DRIEHAUS MUTUAL FUNDS104,9540 00For
Columbia Threadneedle90,9340 00For
Waddell & Reed83,2430 00For
Lincoln Financial81,9220 00For
Equitable72,8950 00For
QUANTITATIVE MASTER SERIES LLC55,3970 00For
Jackson National41,6900 00For
Janus Detroit Street Trust37,6880 00For
RBB FUND, INC.36,7900 00For
Empower31,8070 00For

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

4. Election of Directors: Edward M. Basile

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-22.

Combines 2 wordings of this item as funds reported it.

90% Majority: yes · of votes cast

FOR 90%10%
FOR: 19,518,021AGAINST: 2,128,247

TRANSMEDICS GROUP INC.’s own tally for this item (“Elect Director: Edward M. Basile”): 19,518,021 for, 2,128,247 against, per its Form 8-K filed 2025-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 33,827,880 outstanding shares: 58% for, 6% against (64% of the company cast a for/against vote).

The 92 asset managers below cast 92% of the shares they voted on this item FOR (11,620,691 for, 1,026,068 against).

FOR 92%8%
FOR: 11,620,691 (91.9%)AGAINST: 1,026,068 (8.1%)ABSTAIN: 4,796 (0.0%)
Largest asset managers voting on “Election of Directors: Edward M. Basile” at TRANSMEDICS GROUP INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,478,0924 00For
Fidelity2,943,9490 00For
BlackRock1,642,2360 00For
Delaware/Macquarie0768,488 00Against
MUTUAL FUND SERIES TRUST674,7160 00For
WASATCH FUNDS TRUST333,2150 00For
Royce295,4600 00For
Charles Schwab270,5830 00For
JPMorgan184,1470 00For
Bridge Builder Trust143,4346,045 00For
Invesco148,0790 00For
Brown Capital Management Mutual Funds145,2870 00For
Principal137,7520 00For
FINANCIAL INVESTORS TRUST132,7200 00For
Hartford110,5890 00For
DRIEHAUS MUTUAL FUNDS104,9540 00For
Columbia Threadneedle090,934 00Against
Waddell & Reed083,243 00Against
Lincoln Financial45,68736,235 00For
Equitable72,8950 00For
QUANTITATIVE MASTER SERIES LLC55,3970 00For
Jackson National41,6900 00For
Janus Detroit Street Trust37,6880 00For
RBB FUND, INC.36,7900 00For
Empower31,8070 00For

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

5. Election of Directors: Thomas J. Gunderson

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-22.

Combines 2 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 21,367,800AGAINST: 277,962

TRANSMEDICS GROUP INC.’s own tally for this item (“Elect Director: Thomas J. Gunderson”): 21,367,800 for, 277,962 against, per its Form 8-K filed 2025-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 33,827,880 outstanding shares: 63% for, 0.9% against (64% of the company cast a for/against vote).

The 92 asset managers below cast 99.9% of the shares they voted on this item FOR (12,646,602 for, 157 against).

FOR 99.9%
FOR: 12,646,602 (100.0%)AGAINST: 157 (0.0%)ABSTAIN: 4,796 (0.0%)
Largest asset managers voting on “Election of Directors: Thomas J. Gunderson” at TRANSMEDICS GROUP INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,478,0951 00For
Fidelity2,943,9490 00For
BlackRock1,642,2360 00For
Delaware/Macquarie768,4880 00For
MUTUAL FUND SERIES TRUST674,7160 00For
WASATCH FUNDS TRUST333,2150 00For
Royce295,4600 00For
Charles Schwab270,5830 00For
JPMorgan184,1470 00For
Bridge Builder Trust149,4790 00For
Invesco148,0790 00For
Brown Capital Management Mutual Funds145,2870 00For
Principal137,7520 00For
FINANCIAL INVESTORS TRUST132,7200 00For
Hartford110,5890 00For
DRIEHAUS MUTUAL FUNDS104,9540 00For
Columbia Threadneedle90,9340 00For
Waddell & Reed83,2430 00For
Lincoln Financial81,9220 00For
Equitable72,8950 00For
QUANTITATIVE MASTER SERIES LLC55,3970 00For
Jackson National41,6900 00For
Janus Detroit Street Trust37,6880 00For
RBB FUND, INC.36,7900 00For
Empower31,8070 00For

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

6. Election of Directors: Edwin M. Kania, Jr.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-22.

Combines 2 wordings of this item as funds reported it.

90% Majority: yes · of votes cast

FOR 90%10%
FOR: 19,583,104AGAINST: 2,062,278

TRANSMEDICS GROUP INC.’s own tally for this item (“Elect Director: Edwin M. Kania, Jr.”): 19,583,104 for, 2,062,278 against, per its Form 8-K filed 2025-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 33,827,880 outstanding shares: 58% for, 6% against (64% of the company cast a for/against vote).

The 92 asset managers below cast 99.9% of the shares they voted on this item FOR (12,637,059 for, 9,700 against).

FOR 99.8%
FOR: 12,637,059 (99.9%)AGAINST: 9,700 (0.1%)ABSTAIN: 4,796 (0.0%)
Largest asset managers voting on “Election of Directors: Edwin M. Kania, Jr.” at TRANSMEDICS GROUP INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,478,0924 00For
Fidelity2,943,9490 00For
BlackRock1,642,2360 00For
Delaware/Macquarie768,4880 00For
MUTUAL FUND SERIES TRUST674,7160 00For
WASATCH FUNDS TRUST333,2150 00For
Royce295,4600 00For
Charles Schwab270,5830 00For
JPMorgan184,1470 00For
Bridge Builder Trust143,4346,045 00For
Invesco148,0790 00For
Brown Capital Management Mutual Funds145,2870 00For
Principal137,7520 00For
FINANCIAL INVESTORS TRUST132,7200 00For
Hartford110,5890 00For
DRIEHAUS MUTUAL FUNDS104,9540 00For
Columbia Threadneedle90,9340 00For
Waddell & Reed83,2430 00For
Lincoln Financial81,9220 00For
Equitable72,8950 00For
QUANTITATIVE MASTER SERIES LLC55,3970 00For
Jackson National41,6900 00For
Janus Detroit Street Trust37,6880 00For
RBB FUND, INC.36,7900 00For
Empower31,8070 00For

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

7. Election of Directors: Stephanie Lovell

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-22.

Combines 2 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 21,338,519AGAINST: 305,597

TRANSMEDICS GROUP INC.’s own tally for this item (“Elect Director: Stephanie Lovell”): 21,338,519 for, 305,597 against, per its Form 8-K filed 2025-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 33,827,880 outstanding shares: 63% for, 1.0% against (64% of the company cast a for/against vote).

The 92 asset managers below cast 99.9% of the shares they voted on this item FOR (12,637,089 for, 9,670 against).

FOR 99.8%
FOR: 12,637,089 (99.9%)AGAINST: 9,670 (0.1%)ABSTAIN: 4,796 (0.0%)
Largest asset managers voting on “Election of Directors: Stephanie Lovell” at TRANSMEDICS GROUP INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,478,0951 00For
Fidelity2,943,9490 00For
BlackRock1,642,2360 00For
Delaware/Macquarie768,4880 00For
MUTUAL FUND SERIES TRUST674,7160 00For
WASATCH FUNDS TRUST333,2150 00For
Royce295,4600 00For
Charles Schwab270,5830 00For
JPMorgan184,1470 00For
Bridge Builder Trust143,4346,045 00For
Invesco148,0790 00For
Brown Capital Management Mutual Funds145,2870 00For
Principal137,7520 00For
FINANCIAL INVESTORS TRUST132,7200 00For
Hartford110,5890 00For
DRIEHAUS MUTUAL FUNDS104,9540 00For
Columbia Threadneedle90,9340 00For
Waddell & Reed83,2430 00For
Lincoln Financial81,9220 00For
Equitable72,8950 00For
QUANTITATIVE MASTER SERIES LLC55,3970 00For
Jackson National41,6900 00For
Janus Detroit Street Trust37,6880 00For
RBB FUND, INC.36,7900 00For
Empower31,8070 00For

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

8. Election of Directors: Merilee Raines

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-22.

Combines 2 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 21,421,630AGAINST: 224,815

TRANSMEDICS GROUP INC.’s own tally for this item (“Elect Director: Merilee Raines”): 21,421,630 for, 224,815 against, per its Form 8-K filed 2025-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 33,827,880 outstanding shares: 63% for, 0.7% against (64% of the company cast a for/against vote).

The 92 asset managers below cast 99.6% of the shares they voted on this item FOR (12,607,873 for, 38,886 against).

FOR 99.6%
FOR: 12,607,873 (99.7%)AGAINST: 38,886 (0.3%)ABSTAIN: 4,796 (0.0%)
Largest asset managers voting on “Election of Directors: Merilee Raines” at TRANSMEDICS GROUP INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,478,0960 00For
Fidelity2,943,9490 00For
BlackRock1,642,2360 00For
Delaware/Macquarie768,4880 00For
MUTUAL FUND SERIES TRUST674,7160 00For
WASATCH FUNDS TRUST333,2150 00For
Royce295,4600 00For
Charles Schwab270,5830 00For
JPMorgan184,1470 00For
Bridge Builder Trust149,4790 00For
Invesco148,0790 00For
Brown Capital Management Mutual Funds145,2870 00For
Principal137,7520 00For
FINANCIAL INVESTORS TRUST132,7200 00For
Hartford110,5890 00For
DRIEHAUS MUTUAL FUNDS104,9540 00For
Columbia Threadneedle90,9340 00For
Waddell & Reed83,2430 00For
Lincoln Financial81,9220 00For
Equitable34,76538,130 00Against
QUANTITATIVE MASTER SERIES LLC55,3970 00For
Jackson National41,6900 00For
Janus Detroit Street Trust37,6880 00For
RBB FUND, INC.36,7900 00For
Empower31,8070 00For

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

9. Election of Directors: David Weill, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-22.

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 21,250,720AGAINST: 395,207

TRANSMEDICS GROUP INC.’s own tally for this item (“Elect Director: David Weill, M.D.”): 21,250,720 for, 395,207 against, per its Form 8-K filed 2025-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 33,827,880 outstanding shares: 63% for, 1% against (64% of the company cast a for/against vote).

The 92 asset managers below cast 99.9% of the shares they voted on this item FOR (12,634,155 for, 12,604 against).

FOR 99.8%
FOR: 12,634,155 (99.9%)AGAINST: 12,604 (0.1%)ABSTAIN: 4,796 (0.0%)
Largest asset managers voting on “Election of Directors: David Weill, M.D.” at TRANSMEDICS GROUP INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,478,0951 00For
Fidelity2,943,9490 00For
BlackRock1,642,2360 00For
Delaware/Macquarie768,4880 00For
MUTUAL FUND SERIES TRUST674,7160 00For
WASATCH FUNDS TRUST333,2150 00For
Royce295,4600 00For
Charles Schwab270,5830 00For
JPMorgan184,1470 00For
Bridge Builder Trust143,4346,045 00For
Invesco148,0790 00For
Brown Capital Management Mutual Funds145,2870 00For
Principal137,7520 00For
FINANCIAL INVESTORS TRUST132,7200 00For
Hartford110,5890 00For
DRIEHAUS MUTUAL FUNDS104,9540 00For
Columbia Threadneedle90,9340 00For
Waddell & Reed83,2430 00For
Lincoln Financial81,9220 00For
Equitable72,8950 00For
QUANTITATIVE MASTER SERIES LLC55,3970 00For
Jackson National41,6900 00For
Janus Detroit Street Trust37,6880 00For
RBB FUND, INC.36,7900 00For
Empower31,8070 00For

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

10. To ratify the appointment of PricewaterhouseCoopers LLP as TransMedics Group, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2025.

AUDIT-RELATED

Meeting held 2025-05-22.

Combines 2 wordings of this item as funds reported it.

99.8% fund support · no official result

FOR 99.8%

The 89 asset managers below cast 99.8% of the shares they voted on this item FOR (12,595,289 for, 16,047 against).

FOR: 12,595,289 (99.8%)AGAINST: 16,047 (0.1%)ABSTAIN: 4,796 (0.0%)
Largest asset managers voting on “To ratify the appointment of PricewaterhouseCoopers LLP as TransMedics Group, Inc.'s independent registered pu” at TRANSMEDICS GROUP INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,476,7231,373 00For
Fidelity2,943,9490 00For
BlackRock1,642,2360 00For
Delaware/Macquarie768,4880 00For
MUTUAL FUND SERIES TRUST674,7160 00For
WASATCH FUNDS TRUST333,2150 00For
Royce295,4600 00For
Charles Schwab270,5830 00For
JPMorgan184,1470 00For
Bridge Builder Trust149,4790 00For
Invesco148,0790 00For
Brown Capital Management Mutual Funds145,2870 00For
Principal137,7520 00For
FINANCIAL INVESTORS TRUST132,7200 00For
Hartford110,5890 00For
DRIEHAUS MUTUAL FUNDS104,9540 00For
Columbia Threadneedle90,9340 00For
Waddell & Reed83,2430 00For
Lincoln Financial81,9220 00For
Equitable72,8950 00For
QUANTITATIVE MASTER SERIES LLC55,3970 00For
Jackson National41,6900 00For
Janus Detroit Street Trust37,6880 00For
RBB FUND, INC.36,7900 00For
Allspring31,7100 00For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

11. Ratify PricewaterhouseCoopers LLP as Auditors

AUDIT-RELATED

Meeting held 2025-05-22.

100% fund support · no official result

FOR 100%

The 5 asset managers below cast 100% of the shares they voted on this item FOR (35,423 for, 0 against).

FOR: 35,423 (100.0%)
Largest asset managers voting on “Ratify PricewaterhouseCoopers LLP as Auditors” at TRANSMEDICS GROUP INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Empower25,3530 00For
VALUED ADVISERS TRUST7,1760 00For
CLEARWATER INVESTMENT TRUST2,2000 00For
HC CAPITAL TRUST6930 00For
Brighthouse10 00For

12. To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2024-05-23 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).

Combines 2 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 22,902,359AGAINST: 1,321,627

TRANSMEDICS GROUP INC.’s own tally for this item (“Proposal Two : The shareholders approved, on a non-binding advisory basis, the compensation paid to the Company's named executive officers, based on the following votes:”): 22,902,359 for, 1,321,627 against, per its Form 8-K filed 2024-05-28 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 33,827,880 outstanding shares: 68% for, 4% against (72% of the company cast a for/against vote).

The 2 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 99 against).

AGAINST 100%
AGAINST: 99 (100.0%)
Largest asset managers voting on “To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named executive officers.” at TRANSMEDICS GROUP INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
COLDSTREAM CAPITAL MANAGEMENT INC099 00Against
Echo45 Advisors LLC00 00--

Largest TRANSMEDICS GROUP INC. shareholders voting in 2024-2025

Ranked by the number of TRANSMEDICS GROUP INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 33,827,880 shares outstanding at the time of that meeting.

Top TRANSMEDICS GROUP INC. shareholders by shares voted, 2024-2025
#Asset manager % of shares outstanding
1Fidelity 21.44%
2Vanguard 10.51%
3BlackRock 6.81%
4MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST 2.98%
5Delaware/Macquarie 2.27%
6MUTUAL FUND SERIES TRUST 1.99%
7Charles Schwab 1.70%
8JPMorgan 1.55%
9Liontrust Investment Partners LLP 1.54%
10DRIEHAUS CAPITAL MANAGEMENT LLC 1.48%

Reported TRANSMEDICS GROUP INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

TRANSMEDICS GROUP INC. beneficial owners on record for the 2024-2025 proxy season
Holder % outstanding Disclosure
BlackRock 15.51% 13F
FMR (Fidelity) 14.77% 13F
FMR LLC 12.90% DEF14A
Vanguard Group 10.57% 13F
Vanguard Portfolio Management 5.76% 13G
Waleed H. Hassanein, M.D. 3.89% DEF14A
State Street 3.86% 13F
Citadel Advisors 3.47% 13F
Morgan Stanley 1.77% 13F
Goldman Sachs 1.50% 13F

Percentages above are of 33,827,880 shares outstanding, as reported by TRANSMEDICS GROUP INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from TRANSMEDICS GROUP INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At TRANSMEDICS GROUP INC.'s shareholder meeting held 2025-05-22, in the 2024-2025 proxy season, 347 asset managers reported how they voted in their SEC Form N-PX filings, covering 3,318 separate fund positions. Their filings are grouped here into 12 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named… — FOR was 97% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: TRANSMEDICS GROUP INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-05-23.

TRANSMEDICS GROUP INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.